| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2734 | |||||||||||||||||||||||
| Submitter : | Mrs. Malinda Rauschert | Date & Time: | 12/07/2006 11:12:11 | |||||||||||||||||||||
| Organization : | Mrs. Malinda Rauschert | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I object to the use of human fetal tissue in cell lines, especially that from aborted fetuses as it relies on immoral means. I cannot use the vaccines produced in them. Therefore I encourage the FDA to discourage the proliferation of these types of vaccines, especially given that other organic matter can be used instead. | ||||||||||||||||||||||||